Becker JC, Ugurel S, Leiter U, Meier F, et al. Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial. Lancet 2023;402:798-808.
PMID: 37451295